Johanna Feary

Dr. Johanna Feary


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in Thorax
Verified
Journal Article
Closed access
PDF file
CBChristopher Michael Barber
Christopher Michael Barber
PCPaul Cullinan
Paul Cullinan
JFJohanna Feary
Johanna Feary
DFDavid Fishwick
David Fishwick
JHJennifer Hoyle
Jennifer Hoyle
GWGareth Iestyn Walters
Gareth Iestyn Walters
The Clinical Statement Group (CSG) was chaired by Dr Chris Barber. Membership was drawn from current and former members of the BTS Occupational and Environmental Lung Disease Specialist Advisory Group. The CSG identified key areas requiring clinical practice points. The overall content was developed to reflect the scope approved by the BTS Standards of Care Committee (SOCC). Following discussions of broad statement content, individual sections were drafted by group members. A final edited draft was reviewed by the BTS SOCC before posting for public consultation and peer review on the BTS website (August/September 2021). The revised document was approved by the BTS SOCC in November 2021 before final publication.

6 August 2024 in Thorax
Verified
Journal Article
Open access
PDF file
PHPatrick Howlett
Patrick Howlett
JGJeffrey Gan
Jeffrey Gan
MLMaia Lesosky
Maia Lesosky
JFJohanna Feary
Johanna Feary
Background: Silicosis, a chronic respiratory disease caused by crystalline silica exposure, is a persistent global lung health issue. No systematic review of the relationship between cumulative respirable crystalline silica (RCS) exposure and silicosis exists. UK exposure limits are currently under review. We therefore performed a systematic review and dose-response meta-analysis of this relationship.Methods: Web of Science, Medline and Embase were searched on 24 February 2023. Studies of radiographic, autopsy or death certificate silicosis, with an estimated average follow-up of over 20 years since first employment, were included. Cumulative silicosis risk methods were compared. The relative risks (RR) of silicosis at increasing cumulative exposures were calculated and used to estimate the absolute risk reduction (ARR).Results: Eight eligible studies, including 10 cohorts, contributed 8792 cases of silicosis among 65 977 participants. Substantial differences in cumulative risk estimates between methodologies exist. Using the same method, we observed higher cumulative silicosis risks among mining compared with non-mining cohorts. A reduction from 4 to 2 mg/m³-years in cumulative RCS exposure corresponded to substantial risk reductions among miners (RR 0.23 (95% CI 0.18 to 0.29, I2=92.9%) with an ARR of 323 (95% CI 298 to 344) per 1000) and non-miners (RR 0.55 (95% CI 0.36 to 0.83, I2=77.0%) with an ARR of 23 (95% CI 9 to 33) per 1000).Conclusion: Despite significant heterogeneity, our findings support a reduction in permissible exposure limits from 0.1 mg/m3to 0.05 mg/m³, particularly among mining populations. Further research is needed among non-miners as only two studies were eligible.

15 November 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
VSValentina Quintero Santofimio
Valentina Quintero Santofimio
AAAndré F. S. Amaral
André F. S. Amaral
JFJohanna Feary
Johanna Feary
Exposure to high levels of harmful agents in the workplace can significantly impact workers’ health, contributing to morbidity and mortality. Levels of these exposures are often measured in high-income countries in research studies and, in some places, to monitor levels in line with health and safety regulations. However, less is known about workplace exposure levels in low- and middle-income countries (LMICs). Our aim was to describe the quantitative exposure measurements of different occupational agents across industries within LMICs. We conducted a scoping review of peer-reviewed publications available on Web of Science and PubMed from inception to 1 September 2023. Our search focused on quantitative occupational exposure measurements across industries in LMICs. We identified a total of 8,676 publications. After screening, 58 studies from 25 countries were retained for final review. China, Iran, and Tanzania contributed the greatest number of studies. Manufacturing, mining, and agriculture were the most studied sectors, with factory workers and miners being the most common job titles. Exposure measurements included vapour, gases, dust, and fumes (VGDF), solvents, metals, pesticides and particulate matter. Occupational exposure levels for the same industry varied widely across geographical regions. This review provides a comprehensive overview of occupational exposures in LMICs and highlights the absence of data in certain geographical areas and industries. The study contributes valuable insights for directing future research, and the need to optimise the assessment of occupational exposures in LMICs with the aim ultimately of reducing disease.

6 August 2024 in Thorax
Verified
Journal Article
Open access
PDF file
JFJohanna Feary
Johanna Feary
ADAnand Devaraj
Anand Devaraj
MBMatthew Burton
Matthew Burton
FCFelix Chua
Felix Chua
RCRobina K Coker
Robina K Coker
JSJoanna Szram
Joanna Szram
Silicosis due to artificial stone (AS) has emerged over the last decade as an increasing global issue. We report the first eight UK cases. All were men; median age was 34 years (range 27–56) and median stone dust exposure was 12.5 years (range 4–40) but in 4 cases was 4–8 years. One is deceased; two were referred for lung transplant assessment. All cases were dry cutting and polishing AS worktops with inadequate safety measures. Clinical features of silicosis can closely mimic sarcoidosis. UK cases are likely to increase, with urgent action needed to identify cases and enforce regulations.

13 June 2023 in Breathe
Verified
Journal Article
Open access
PDF file
JFJohanna Feary
Johanna Feary
ILIrmeli Lindstrom
Irmeli Lindstrom
CHChristopher C. Huntley
Christopher C. Huntley
HSHille Suojalehto
Hille Suojalehto
RHRafael E. de la Hoz
Rafael E. de la Hoz
Exposure to toxic inhalants in the workplace has the potential to cause (in susceptible individuals) almost any major type of lung disease, such as asthma, COPD and interstitial lung diseases. Patients with occupational lung disease will often present to or will be managed by respiratory specialists without training in occupational respiratory medicine, and patients (or their clinicians) may not identify a link between their disease and their current or a past job. Without an awareness of the range of different occupational lung diseases that exist, their similarity to their non-occupational counterparts, and without directed questioning, these conditions may go unidentified. Patients with occupational lung diseases are often in lower paid work and are disproportionally affected by health inequality. Both clinical and socioeconomic outcomes generally improve if cases are identified early. This allows appropriate advice to be given about the risks of ongoing exposure, clinical management, occupational mobility and, in some cases, eligibility for legal compensation. As respiratory professionals, it is important that these cases are not missed, and if needed, are discussed with a physician with specialised expertise. Here we describe some of the most common occupational lung diseases and outline the diagnostic and treatment approach.

16 July 2022 in Current Opinion in Pulmonary Medicine
Verified
Journal Article
Closed access
CLCathryn T. Lee
Cathryn T. Lee
JFJohanna Feary
Johanna Feary
KJKerri A. Johannson
Kerri A. Johannson
Purpose of review: We highlight recent advances in the understanding of how environmental and occupational exposures increase the risk of developing interstitial lung disease (ILD), and how to evaluate a patient for potential exposures. Recent findings: A review of emerging literature suggests that environmental and occupational exposures can be directly causal, as in the case of the pneumoconioses and smoking-related ILDs, or one of many contributors to disease, as in the case of idiopathic pulmonary fibrosis (IPF). Regardless of the level of association, exposures are clearly prevalent across all ILD subtypes studied. Summary: Inhalational exposures are increasingly recognized as an important component in the development of ILDs, and novel exposure-disease associations continue to be discovered. These exposures represent potential opportunities for further understanding the pathobiology of disease and for the prevention of these often progressive and debilitating disorders. Prospective, comprehensive data collection regarding occupational and environmental exposures are needed in ILD patients to fully elucidate specific antigens and their relationships to disease incidence and outcomes. Systematically collected exposure information will also inform potential interventions to remediate exposures and thus mitigate the course of frequently progressive and fatal diseases.